XML 26 R15.htm IDEA: XBRL DOCUMENT v3.5.0.2
4. STOCKHOLDERS' EQUITY (Tables)
 9 Months Ended
Sep. 30, 2016
Stockholders' Equity Note [Abstract]  
A Summary Of The Status Of The Warrants Granted
  For the Nine Months Ended September 30, 2016      
    Shares     Weighted Average Exercise Price  
Outstanding at beginning of period     9,736,844     $ 0.19  
  Granted     60,000,000       0.12  
  Exercised     -       -  
  Forfeited     -       -  
  Expired     1,990,544       0.48  
Outstanding at end of period     67,746,300     $ 0.12  
Schedule of warrants by warrant price range
        As of September 30, 2016   As of September 30, 2016
        Warrants Outstanding   Warrants Exercisable
  Range of Exercise Prices     Number Outstanding     Weighted-Average Remaining Contract Life     Weighted- Average Exercise Price   Number Exercisable     Weighted-Average Exercise Price
  $ 0.06       4,500,000       2.0     $ 0.06     4,500,000     $ 0.06
    0.075       550,000       1.4       0.08     550,000       0.08
    0.09       625,000       1.5       0.09     625,000       0.09
    0.12       60,000,000       4.6       0.12     12,000,000       0.12
    0.15       1,571,300       0.9       0.15     1,571,300       0.15
    0.60       500,000       0.3       0.60     500,000       0.60
  $ 0.06-0.60       67,746,300       4.2     $ 0.12     19,746,300     $ 0.12
Schedule of option activity
  For the Nine Months Ended September 30, 2016    
    Options     Weighted Average Exercise Price  
Outstanding at beginning of period     1,093,500     $ 0.15  
  Granted     -       -  
  Exercised     -       -  
  Forfeited     -       -  
  Expired     -       -  
Outstanding at end of Period     1,093,500     $ 0.15  
Schedule of options by option price range
        As of September 30, 2016     As of September 30, 2016  
        Stock Options Outstanding     Stock Options Exercisable  
  Exercise Price     Number Outstanding     Weighted-Average Remaining Contract Life     Weighted- Average Exercise Price     Number Exercisable     Weighted-Average Exercise Price  
  $ 0.15       943,500       1. 0       0.15       943,500     $ 0.15  

 

(a)

 

       150,000     -     -     -     -  
  $ 0.15       1,093,500       1. 0       0.15       943,500     $ 0.15  

 

(a) On January 1, 2015, the company granted three tranches of options, 25,000, 25,000, and 100,000 which vest upon meeting specific performance measures agreed upon. The measures include achieving three specific sales targets per month for 3 consecutive months. The exercise price and expiration date of each tranche will be set upon achieving the targets. As of the date of this filing the performance measures have not been met. As a result the exercise price is undetermined and these options are excluded from the calculation of weighted average remaining life.